PCK1 and metabolic disease: Taking into account that upregulated PCK1 in type 2 diabetic patients correlates with increased rates of gluconeogenesis in the liver of humans53, it is plausible to assume that p53 is somehow involved in the PCK1-related metabolic disorders.